Peter A. Jaslow

Jan 22, 2025 | jdsupra.com | Margaret Brivanlou Ph.D |Peter A. Jaslow |Philip Legendy

Ballard Spahr attorneys from the firm’s Life Sciences and Health Care Industry Teams were on the ground in sunny San Francisco for the 43rd Annual J.P. Morgan Health Care Conference (#JPM25) January 12-15. The weather was vibrant and so was the atmosphere, with ample opportunity for networking and collaboration among prominent participants. KEY TAKEAWAYS: Cautious Optimism for Deal Making.

Jan 22, 2025 | ballardspahr.com | Margaret Bolce Brivanlou |Peter A. Jaslow |Philip Legendy |Scott D. Marty

Ballard Spahr attorneys from the firm’s Life Sciences and Health Care Industry Teams were on the ground in sunny San Francisco for the 43rd Annual J.P. Morgan Health Care Conference (#JPM25) January 12-15. The weather was vibrant and so was the atmosphere, with ample opportunity for networking and collaboration among prominent participants. KEY TAKEAWAYS: Cautious Optimism for Deal Making.

Apr 24, 2024 | jdsupra.com | Siana Danch |Peter Hardy |Peter A. Jaslow

On April 18, the Internal Revenue Service (“IRS”) issued a draft version of Form 1099-DA, a proposed information reporting form regarding certain digital asset sales and exchanges that “digital asset brokers” will need to file with the IRS and provide to the individuals involved in the sales and exchanges (“Draft Form”). The detailed and complicated Draft Form would be the first of its kind.

Apr 23, 2024 | lexblog.com | Peter Hardy |Christopher Jones |Marjorie Peerce |Peter A. Jaslow

On April 18, the Internal Revenue Service (“IRS”) issued a draft version of Form 1099-DA, a proposed information reporting form regarding certain digital asset sales and exchanges that “digital asset brokers” will need to file with the IRS and provide to the individuals involved in the sales and exchanges (“Draft Form”). The detailed and complicated Draft Form would be the first of its kind.

Jan 22, 2024 | jdsupra.com | Margaret Brivanlou Ph.D |Peter A. Jaslow |Philip Legendy

Ballard Spahr attorneys from the firm’s Life Sciences and Health Care Industry Teams were on the ground for the 42nd Annual J.P. Morgan Healthcare Conference (JPM24) from January 7-10. While still less crowded than pre-pandemic levels, there was a general air of optimism that had been missing last year and the discussions were as compelling as ever at the premier gathering of global industry leaders, emerging companies, technology creators, and the investment community.